In­cyte ponies up $12M to set­tle char­i­ty foun­da­tion kick­back claims; US ex­er­cis­es op­tion for more dos­es of mon­key­pox vac­cine

One in a string of law­suits tar­get­ing co­pay char­i­ty foun­da­tions, the DOJ has been hunt­ing drug­mak­er In­cyte for what pros­e­cu­tors al­leged was a kick­back scheme to court pa­tients. Now, In­cyte is clear­ing its name.

In­cyte will shell out $12.6 mil­lion to set­tle claims it fun­neled funds through a char­i­ty foun­da­tion to cov­er fed­er­al co­pays for pa­tients tak­ing its JAK in­hibitor Jakafi, the DOJ said this week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER